Pharmaceutical markets experience the entry of numerous generic firms upon expiration of the brand firm's patent. In this paper, we take a close look at competition among the generic entrants during the first three years after patent expiration and examine whether there is a first mover...

Past research has primarily focused on what happens after a merger has occurred. This research attempts to find out whether anticipated benefits from the merger do actually accrue. The authors characterize the effects of observed variables on whether pairs of firms merge, vis-à-vis roommate...

While innovation and growth can be promoted internally through focus on research and development (R&D), many firms find acquisition from external sources to be a fast and attractive alternative. Despite the numerous theories of merger and acquisition in the literature, no empirical study has...